Company news
Cantourage Group Se (XETR:HIGH) news
Every Cantourage Group Se press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
September 11, 2026
Cantourage Group SE: Early Departure of the Chairman of the Management Board
September 10, 2026
Cantourage : Publishes Initial Guidance for Financial Year 2026
August 31, 2026
Cantourage Group SE: Cantourage Group SE Publishes Initial Guidance for Financial Year 2026
August 31, 2026
Cantourage Group SE increases EBITDA by 45 percent in the second quarter of 2026 – strategic focus on high-margin business pays off
August 13, 2026
Cantourage welcomes clarification on the implementation of the German GKV-FinStG
August 7, 2026
Cantourage Launches Proprietary Medical Cannabis Brand gramz. in Germany
July 15, 2026
Cantourage Group SE: Monique Jaqqam, Acceptance of the granting of 25,000 stock options (subscription rights to shares of Cantourage Grou...
June 5, 2026
Cantourage Group SE: Philip Schetter, Acceptance of the granting of 25,000 stock options (subscription rights to shares of Cantourage Gro...
June 5, 2026
Cantourage Group SE // Cantourage Significantly Increases Profitability in the First Quarter of 2026
May 11, 2026
Cantourage Group SE: U.S. Cannabis Rescheduling Highlights Global Growth Potential – Europe Comes into Focus
April 24, 2026
Cantourage Group SE publishes preliminary figures for 2025 – Revenue rises to EUR 92.8 million
March 17, 2026
Cantourage Group SE expects EBITDA for 2025 to exceed current market expectations based on preliminary figures
December 19, 2025
Cantourage appoints new member to its Management Board: Monique Jaqqam becomes Chief Financial Officer – Supervisory Board prolongs CEO P...
December 9, 2025
Cantourage strengthens market presence in Poland with flower variety “Gelato 33”
November 4, 2025
Q3 2025: Cantourage delivers strong operating performance in a challenging regulatory market environment
October 30, 2025
Cabinet decision on the Medical Cannabis Act meets broad criticism / Cantourage expects changes and prepares to expand its “Telecan” plat...
October 15, 2025
Cantourage is responding to potential developments resulting from new legal regulations with focused internationalization and strategic p...
October 8, 2025
Cantourage Strengthens Capital Markets Presence: New Head of Investor Relations and Strategic Focus on Europe
October 1, 2025
Ad hoc: Cantourage significantly increases profitability and revenue – EBITDA margin of 11 to 13% in the first quarter of 2025
May 20, 2025
Cantourage achieves another record revenue: EUR 11.1 million in April 2025
May 15, 2025
Ad-hoc: Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 2025 - for the first time more than EUR 10.7 million revenue ...
April 10, 2025
Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 – for the first time more than EUR 10.7 million revenue in one month
April 10, 2025
Legalization of cannabis brings strong growth: Cantourage Group SE increases its sales by 118% to EUR 51.4 million in full year 2024
January 15, 2025
Cantourage Group SE exports medical craft cannabis for the first time to the growth market of Poland; cooperation with the wholesaler Pha...
December 19, 2024
New Sales Record: Cantourage Group SE Reports EUR 5.5 Million in Revenue for October 2024, Reaffirming Full-Year Growth Targets
November 20, 2024
Strong EBITDA growth: Cantourage Group SE posts EBITDA of EUR 1.4 million in third quarter of 2024 and sets course for further profitable...
November 7, 2024